 The companys patent portfolio includes its own intellectual property and exclusive worldwide licenses, including in the U.S., Canada, Europe, Australia, Hong Kong, and China 180 Life Sciences is in the final stages of its merger process with KBL Merger Corp. IV, with the resulting entity to list on NASDAQ under the ticker ATNF The company ... Continue reading 180 Life Sciences Corp. Expands IP Portfolio with EU, U.S., and Chinese Patents 